The MECOM gene helps guide how certain blood-forming stem cells grow and mature, which supports healthy levels of platelets, red blood cells, and infection-fighting white blood cells. The protein made by this gene helps your cells control which other genes are turned on or off during blood development. When MECOM does not work well, some people can develop very low platelets and bone marrow failure, leading to easy bruising or bleeding, tiredness from anemia, and more frequent infections. Some may also have arm bone differences such as fused forearm bones. Changes involving MECOM are also seen in some leukemias, where they can influence how the disease behaves.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or manage activities in your body. Some genes provide the code for producing proteins, which act as the cell’s functional parts. Others are mostly involved in regulating when and where certain actions happen, and how much they happen. Taken as a whole, genes affect how your body grows and works, and they may influence how you react to things like diet, stress, or medicines. For a deeper look at this subject, you can find more information in the LearnHub.
Overview
MECOMGene function
What if the gene works
The MECOM gene helps control how certain cells turn genes on and off, especially in the bone marrow. This supports normal blood cell development and the balance of early stem cells. It also contributes to growth and development before birth.
Risk
What if the gene does not work
Changes in the MECOM gene can disrupt bone marrow blood production, leading to low platelets and sometimes other low blood counts with bruising, bleeding, or infections. Variants range from mild to severe, affecting onset and whether limb differences appear.
Treatment
What does that mean for your treatment
MECOM variants can influence timing and approach to hematopoietic stem cell transplant and follow up of blood counts. For marrow failure, transplant may be the main definitive option, and related donors are typically screened to avoid using a carrier.
Conditions associated with MECOM
Gene function
What if the gene works
In everyday life, your cells constantly need to “choose” which instructions to use and which to keep quiet. The MECOM gene helps manage those choices by guiding gene activity inside the cell nucleus. This supports normal cell growth, cell maturity, and early development, especially in tissues that must keep renewing throughout life.
The MECOM gene provides a DNA-binding protein (a protein that attaches to DNA) that can switch many other genes on or off. This helps cells follow the right set of instructions for their job at a given time.
A key part of MECOM gene function is supporting early blood-forming cells in the bone marrow. This helps the body keep a steady supply of new blood cells as older cells wear out.
This gene helps coordinate signals that tell cells when to grow and when to begin specializing into a more specific cell type. That balance supports healthy tissue maintenance and renewal in many parts of the body.
MECOM activity is important during embryonic development, when the body is building organs and tissues. It helps organize broad gene programs so developing cells mature in a coordinated way.
What is a variant?
A genetic variant is a minor difference in the DNA code within a gene. These differences occur often and help explain normal variation among people, such as differences in appearance, metabolism, or how the body reacts to environmental factors. Many variants do not cause any noticeable changes and are part of typical genetic diversity. In certain situations, though, a variant can affect how a gene works more strongly and may play a role in, or lead to, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the MECOM gene can weaken the body’s ability to make healthy blood cells, especially platelet-making cells, which may show up as easy bruising, frequent nosebleeds, or low platelets on a blood test. A MECOM gene mutation can range from milder variants that leave some activity to more severe mutations that greatly reduce it. This spectrum can influence how early problems start, how low blood counts become, and whether features like forearm bone fusion or kidney differences appear. Some variants are also linked to bone marrow failure later in life.
How variants are linked to conditions
Some people with a pathogenic MECOM gene change can develop an inherited bone marrow failure condition, often with low platelets (thrombocytopenia) and sometimes forearm bone differences such as radioulnar synostosis (RUSAT2). In certain families, a MECOM gene mutation can lead to long-term low blood counts, including aplastic anemia. Separately, acquired (non-inherited) MECOM changes found in blood or bone marrow cells are linked to myelodysplastic syndromes and acute myeloid leukemia.
A variant is not necessarily a diagnosis
Changes in DNA are a typical feature of human biology, and they occur frequently across the general population. The majority of these variants do not directly impact health and instead represent normal human variation. With many genes, having a variant that has been connected with a condition points to a potential association rather than a confirmed diagnosis, particularly when more than one gene and environmental influences contribute. Still, in certain situations, one clearly defined variant in a particular gene can be enough to establish a diagnosis.
Are there things that can increase or change my risk?
With a harmful change in the MECOM gene, the chance of developing related blood and bone marrow problems is largely set by the gene change itself, and lifestyle steps have not been proven to prevent it. Risk can still shift with things like infections, major illness, or medicines that increase bleeding or suppress bone marrow. Regular checkups and quick care for unusual bruising, bleeding, or frequent infections help prevent complications.
Inheritance of MECOM variants
Variants in the MECOM gene most often follow an autosomal dominant MECOM gene inheritance pattern, meaning one changed copy can be enough to cause a MECOM-related condition. You can inherit it from either parent, and each child has a 50% chance of inheriting the same variant. Some people have a new (de novo) MECOM variant that was not inherited from either parent.
What does my MECOM result mean for my family?
Seek medical advice if you or a family member with a MECOM result has easy bruising or bleeding, frequent infections, unusual tiredness, or very pale skin, as these can relate to low blood counts. A genetics or blood specialist can explain what the MECOM change may mean for relatives, including children. They can also guide follow-up care and treatment choices, such as closer monitoring and, in some cases, transplant planning.
Genetic information
Genetic testing
How you find out about variants
Genetic testing can identify changes in the MECOM gene by reading your DNA from a blood draw or saliva sample. Clinicians often order testing for MECOM gene variants as part of a multigene panel, exome, or genome test, and the lab compares your sequence with reference data. Results are reported as benign, uncertain, or pathogenic, which helps guide next steps.
When should I consider getting a genetic test?
Consider genetic testing for the MECOM gene if you or your child has long-lasting low platelets (easy bruising or nosebleeds), unexplained anemia (low red blood cells), or other ongoing abnormal blood counts. Testing can also help when there is a family history of bone marrow failure, low blood counts, or certain blood cancers at younger ages.
A genetic result is only one part of your health story
A genetic test result can be very informative, but its value varies based on the health condition and the specific kind of genetic variant found. Your body’s health over time is shaped by many factors, including lifestyle, environment, age, and medical history. With some conditions, particularly those affected by many genes, genetic findings offer helpful context rather than a definite prediction and make the most sense when considered together with other parts of your care. In other situations, genetic information can be more straightforward and provide a clear explanation. For topics like how someone responds to medications, genetic results can also help interpret personal experiences in a broader context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines, including how strongly a drug works and how likely side effects are. Changes in genes can influence drug-handling proteins in the liver and gut, or the drug’s target in the body, so the same dose can lead to different drug levels and effects in different people. This kind of difference is common and is one reason a medication may help one person but cause more side effects or less benefit in another. The MECOM gene is best known for its role in controlling cell growth and blood cell development, and it is not typically used on its own as a standard guide for everyday medication selection or dosing.
What is Pharmacogenetics?
Pharmacogenetics focuses on how inherited genetic differences can affect the way you respond to medications. It examines relationships between specific genes and specific drugs to explain why the same treatment may not work the same way for everyone. With many medicines, your genes can influence how powerfully a drug works or how your body breaks it down. Understanding these gene related effects can support more informed, more personalized treatment choices. More detailed information on this subject is available in the LearnHub.
Drugs influenced by the MECOM gene
When should I seek medical advice?
Seek medical advice for unexplained low blood counts—ongoing tiredness, frequent infections, or easy bruising or bleeding—especially with a family history of bone marrow problems. If you have a known MECOM change, talk with your care team before chemotherapy or other medicines that can lower blood counts, since this may affect monitoring and treatment choices.
History
The MECOM gene came to medical attention through cancer research, after scientists found that changes in a specific stretch of DNA at chromosome 3q26 showed up repeatedly in certain leukemias and related blood disorders. Over time, descriptions became more precise as researchers connected these 3q26 rearrangements to overactivity of the EVI1 region within MECOM. This work helped establish MECOM as an important marker in the classification of some myeloid cancers. In the following years, improved genetic testing made it easier to detect MECOM rearrangements in clinical samples. More recently, doctors recognized that some inherited changes in the MECOM gene can also be linked to rare syndromes involving low platelet production and bone or limb differences. These milestones broadened MECOM’s role from a research finding to a gene with clear clinical relevance in both cancer and inherited conditions.